The effect of Astaxanthin on the expression of genes involved in WNT/ß-catenin pathway in granulosa cells and inflammatory factors in the serum of PCOs patients candidate for ART

INTERVENTION: Intervention 1: Astaxanthin group: In this group, patients will receive a 6 mg astaxanthin tablet daily for two months after eating. Intervention 2: Control group: In this group, patients will receive a 6 mg placebo tablet daily for two months after eating. CONDITION: E28.2 Poly cystic ovarian syndrome. ; Polycystic ovarian syndrome PRIMARY OUTCOME: Measuring the expression level of Wnt/ß‐catenin signaling pathway genes in patients' granulosa cells. Timepoint: Two months after the start of astaxanthin. Method of measurement: Real time PCR test. Measuring the level of expression of the phosphorylated and dephosphorylated form of beta‐catenin protein. Timepoint: Two months after the start of astaxanthin. Method of measurement: Western blot test. Measurment of serum cytokine levels in patients with polycystic ovary syndrome. Timepoint: At the beginning of the study before the start of the intervention and two months after the start of astaxanthin. Method of measurement: ELIZA. SECONDARY OUTCOME: Checking the quality of oocytes. Timepoint: Two months after taking astaxanthin. Method of measurement: Observation with inverted microscope. Checking the rate of fertilization fertilization. Timepoint: Two months after taking astaxanthin. Method of measurement: Observation with microscope. INCLUSION CRITERIA: Diagnosis of Poly cystic ovary syndrome based on Rotterdam criteria People are in the age range of 18 to 40 years